A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Bapta tetrasodium salt hydrate | Heterocyclic Organic Compound. Alternative Names: BAPTA-Na4, 126824-24-6, Tetrasodium 1,2-bis(2-aminophenoxy)ethane-N,N,N,N-tetraacetate, 1,2-Bis(2-aminophenoxy)ethane-N,N,N,N-tetraacetic acid tetrasodium salt, BAPTA tetrasodium, AC1MC2BW, SureCN590721, AGN-PC-015JOP, 14513_FLUKA, 14513_SIGMA, CTK8E6680, MolPort-003-926-484, AKOS015914724, AKOS016007522, AK-49340, I14-41300, 1,2-Bis (2-aminophenoxy) ethane-N,N,N inverted exclamation marka,N inverted exclamation marka-tetraacetic acid tetrasodium salt, 1,2-Bis(2-aminophenoxy)ethane-N,N,N inverted exclamation marka,N inverted exclamation marka-tetraacetic acid tetrasodium salt, Tetrasodium 1,2-bis(2-aminophenoxy)ethane-N,N,N inverted exclamation marka,N inverted exclamation marka-tetraacetate, tetrasodium 2-[2-[2-[2-[bis(2-oxido-2-oxoethyl)amino]phenoxy]ethoxy]-N-(2-oxido-2-oxoethyl)anilino]acetate. CAS No. 126824-24-6. Molecular formula: C22H20N2Na4O10. Mole weight: 564.37(anhy). Appearance: beige powder. Purity: 0.96. IUPACName: tetrasodium; 2-[2-[2-[2-[bis (carboxylatomethyl) amino]phenoxy]ethoxy]-N- (carboxylatomethyl) anilino]acetate. Catalog: ACM126824246. |  |
| BAPTA-TMFM | BAPTA-TMFM. Group: Biochemicals. Alternative Names: Tetramethyl 5-formyl-5'-methyl bis-(2-aminophenoxymethylene)-N,N,N',N'-tetraacetate; N-[2-[2-[2-[Bis(2-methoxy-2-oxoethyl)amino]-5-formylphenoxy]ethoxy]-4-methylphenyl]-N-(2-methoxy-2-oxoethyl)-glycine methyl ester; BAPTA-TMFM. Grades: Highly Purified. CAS No. 96315-11-6. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C28H34N2O11. US Biological Life Sciences. |  Worldwide |
| Baquiloprim | Baquiloprim. Group: Biochemicals. Grades: Highly Purified. CAS No. 102280-35-3. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C17H20N6. US Biological Life Sciences. | Worldwide |
| Baquiloprim | Heterocyclic Organic Compound. Alternative Names: BAQUILOPRIM;2,4-Pyrimidinediamine, 5-8-(dimethylamino)-7-methyl-5-quinolinylmethyl-;5-[(2,4-Diamino-5-pyrimidinyl)methyl]-N,N-dimethyl-7-methyl-8-quinolinamine. CAS No. 102280-35-3. Molecular formula: C17H20N6. Mole weight: 308.387. Density: 1.288 g/cm³. Catalog: ACM102280353. | |
| Baquiloprim-d6 | 2H Labeled Compounds. CAS No. 1228182-50-0. Molecular formula: C17H14D6N6. Mole weight: 314.42. Catalog: ACM1228182500. | |
| Baquiloprim Impurity 1 | Baquiloprim Impurity 1. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1228182-50-0. Molecular Formula: C17H14D6N6. Mole Weight: 314.43. Catalog: APB1228182500. |  |
| Baquiloprim Impurity 2 | Baquiloprim Impurity 2. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1608116-38-6. Molecular Formula: C17H16Cl2N4. Mole Weight: 347.24. Catalog: APB1608116386. | |
| Baquiloprim Impurity 3 | Baquiloprim Impurity 3. Uses: For analytical and research use. Group: Impurity standards. CAS No. 83028-30-2. Molecular Formula: C17H18N4O2. Mole Weight: 310.36. Catalog: APB83028302. | |
| Baquiloprim Impurity 4 | Baquiloprim Impurity 4. Uses: For analytical and research use. Group: Impurity standards. CAS No. 83028-27-7. Molecular Formula: C15H14N4O2. Mole Weight: 282.3. Catalog: APB83028277. | |
| BAR-501 | BAR-501, a UDCA derivative, is a selective GPBAR1 agonist devoid of any FXR agonistic activity. BAR-501 effectively transactivates GPBAR1 in HEK293 cells overexpressing a CRE along with GPBAR1, with a EC50 of 1 μM. Besides, it protects against development of portal hypertension in rodent models of liver injury and endothelial dysfunction. Synonyms: 3R,5S,6S,7S,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol; BAR-501; BAR 501; BAR501. CAS No. 1632118-69-4. Molecular formula: C26H46O3. Mole weight: 406.651. |  |
| BAR502 | BAR502 is a dual FXR and GPBAR1 agonist (IC50= 2 μM and 0.4 μM for FXR and GPBAR1, respectively). Synonyms: BAR-502; BAR 502; BAR502; (5S,8S,9R,10S,13R,14S,17R)-6-ethyl-17-(4-hydroxybutan-2-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol. CAS No. 1612191-86-2. Molecular formula: C25H44O3. Mole weight: 392.62. | |
| Barasertib | Barasertib is an orally bioavailable, small-molecule, dihydrogen phosphate prodrug of the pyrazoloquinazoline Aurora kinase inhibitor AZD1152-hydroxyquinazoline pyrazol anilide (AZD1152-HQPA) with potential antineoplastic activity. Synonyms: AZD1152; AZD-1152; AZD 1152; Barasertib. CAS No. 722543-31-9. Molecular formula: C26H31FN7O6P. Mole weight: 587.54. | |
| Barasertib | Barasertib. Group: Biochemicals. Alternative Names: AZD1152-HQPA. Grades: Highly Purified. CAS No. 722544-51-6. Pack Sizes: 2mg, 5mg, 10mg, 25mg, 50mg. Molecular Formula: C26H30FN7O3. US Biological Life Sciences. | Worldwide |
| Barbamide | Barbamide is produced by the strain of Lyn-gbya majiuscula. It has the activity of killing mollusks. Synonyms: CHEBI:80028. Molecular formula: C20H23Cl3N2O2S. Mole weight: 461.83. | |
| Barbatic acid | Barbatic acid is a substance obtained from Cladia aggregata (lichen), which exhibits schistosomiasis effect on adult Schistosoma mansoni. CAS No. 17636-16-7. Molecular formula: C19H20O7. Mole weight: 360.36. | |
| Barberry Extract | Barberry Extract. Applications: Used for health care products, dietary supplements, herb medecine to antihistamine and anti-allergy. Group: Others. Synonyms: Barberry Extract; 117-74-8; Berberis vulgaris L. CAS No. 117-74-8. Purity: 60% Berberine by HPLC. Appearance: Yellowish fine powder. Storage: 2 years under well storage situation and stored away from direct sun light. Source: Bark. Species: Berberis vulgaris L. Barberry Extract; 117-74-8; Berberis vulgaris L.; plant extract. Pack: 25KG/Drum with double plastic bag of foodstuff inside. Cat No: EXTW-127. |  |
| Barberry Root Bark Powde | Barberry Root Bark Powde. |  CA, FL & NJ |
| Barbital | Barbital. Group: Biochemicals. Alternative Names: 5,5-Diethyl-2,4,6(1H,3H,5H)-pyrimidinetrione; 5,5-Diethyl-barbituric acid; 5,5-Diethylbarbituric acid. Grades: Purified. CAS No. 57-44-3. Pack Sizes: 2mg, 5mg, 10mg, 25mg, 50mg. Molecular Formula: C8H12N2O3. US Biological Life Sciences. | Worldwide |
| Barbital (BSA) | Barbiturates are a class of around 12 compounds derivatized from barbituric acid. They are central nervous system (CNS) depressants and can be used as sedatives, hypnotics, anaesthetics and anti-epileptic drugs. Barbiturates can be divided into three main groups according to their duration of action. The ultra-short-acting barbiturates are used clinically as anaesthetics while the long-acting barbiturates have anti-convulsant properties. The short-acting compounds are typically used as hypnotics. The short-acting barbiturates are extensively metabolised by the liver to more pharmacologically inactive hydroxylated compounds. Only a small proportion of parent compound (<0.2%) appears in the urine collected after 24 hours. However, with large doses, there is usually sufficient of the parent compound present to give an adequate response and some of the hydroxylated metabolites will also crossreact in immunoassays. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Barbital Sodium | Barbital Sodium. Uses: For analytical and research use. Group: Api standards; pharmaceutical toxicology. Catalog: APS005974. Format: Neat. Shipping: Room Temperature. | |
| barbiturase | Contains zinc and is specific for barbiturate as substrate. Forms part of the oxidative pyrimidine-degrading pathway in some microorganisms, along with EC 1.17.99.4 (uracil/thymine dehydrogenase) and EC 3.5.1.95 (N-malonylurea hydrolase). It was previously thought that the end-products of the reaction were malonate and urea but this has since been disproved. May be involved in the regulation of pyrimidine metabolism, along with EC 2.4.2.9, uracil phosphoribosyltransferase. Group: Enzymes. Enzyme Commission Number: EC 3.5.2.1. CAS No. 9025-16-5. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4492; barbiturase; EC 3.5.2.1; 9025-16-5. Cat No: EXWM-4492. | |
| Barbiturate (BSA) | Barbiturates belong to the group of medicines called central nervous system (CNS) depressants (medicines that cause drowsiness). They affect GABA receptors (like GHB) and thereby bring about a general inhibition of the activity of the CNS, especially that part of the brain stem which governs the rhythm of waking and sleeping. Some of the barbiturates may be used before surgery to relieve anxiety or tension. The only activating stimuli which are not inhibited by barbiturates are pain stimuli. In addition, some of the barbiturates are used as anticonvulsants to help control seizures in certain disorders or diseases, such as epilepsy. Barbiturates have been used to treat insomnia but if they are used regularly (for example, every day) for insomnia, they are usually not effective for longer than 2 weeks. Barbiturates have also been used to relieve nervousness or restlessness during the daytime. Barbiturates have generally been replaced by safer medicines for the treatment of insomnia and d Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Barbituric acid | Barbituric acid (BA) may be used in the preparation of the corresponding hemiaminals, via chemoselective reduction in the presence of SmI2/H2O reagent. It may be used in the preparation of BA- modified conjugated carbon nitride nanosheets. Barbituric acid is a useful acid for organic and drug syntheses. Its dihydrate form can be synthesized from barbituric acid via crystallization from aqueous solution. Crystal structure of barbituric acid (in tautomeric form) has been investigated by a three dimensional fourier transform method. Its enol crystal form has been reported to be thermodynamically stable. Group: Biochemicals. Alternative Names: 2,4,6(1H,3H,5H)-Pyrimidinetrione; 1,2,3,4,5,6-Hexahydro-2,4,6-pyrimidinetrione; 2,4,6-Pyrimidinetriol; 2,4,6-Pyrimidinetrione; 2,4,6-Trihydroxypyrimidine; 2, 4, 6-Trioxohexa hydropyrimidine; 6-Hydroxyuracil; Hexahydropyrimidine-2,4,6-trione; Malonylurea; NSC 7889; Fluorouracil. Grades: Purified. CAS No. 67-52-7. Pack Sizes: 100g, 500g. US Biological Life Sciences. | Worldwide |
| Barbituric Acid Impurity 1 | Barbituric Acid Impurity 1. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 5-allyl-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione. CAS No. 94154-89-9. Molecular Formula: C9H12N2O3. Mole Weight: 196.2. Catalog: APB94154899. | |
| Bardoxolone | Bardoxolone is a synthetic oleanane triterpenoid that exerts multifunctional activities in the control of cellular growth and differentiation. Bardoxolone is capable of activating the transcription factor peroxisome proliferator activator receptor-γ (PPARγ), its apoptotic effects in malignant cells have been shown to occur independently of PPAR&gamma. Bardoxolone was developed as an potential drug for the improvement of hyperglycemia, proteinuria, glomerulus structure, serum creatine, which may in turn be beneficial to treat diabetic kidney diseases, cancer and thromboembolic events. Synonyms: CDDO; RTA 401; RTA401; RTA-401. Grades: >98%. CAS No. 218600-44-3. Molecular formula: C31H41NO4. Mole weight: 491.66. | |
| Bardoxolone | Bardoxolone. Group: Biochemicals. Grades: Highly Purified. CAS No. 218600-44-3. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. US Biological Life Sciences. | Worldwide |
| Bardoxolone methyl | Bardoxolone methyl (NSC 713200; RTA 402; CDDO Methyl ester) is a synthetic triterpenoid compound with potential antineoplastic and anti-inflammatory activities, acting as an activator of the Nrf2 pathway and an inhibitor of the NF-κB pathway. Group: Inhibitors. Alternative Names: Bardoxolone methyl;CDDO-Me;CDDO methyl ester;218600-53-4;RTA 402;NSC 713200;NSC713200;RTA-402;RTA402;UNII-CEG1Q6OGU1;CEG1Q6OGU1;NSC-713200;bardoxolone-methyl;(4aS, 6aR, 6bS, 8aR, 12aS, 14aR, 14bS)-methyl 11-cyano-2, 2, 6a, 6b, 9, 9, 12a-heptamethyl-10, 14-dioxo-1, 2, 3, 4, 4a, 5, 6, 6a, 6b, 7, 8, 8a, 9, 10, 12a, 14, 14a, 14b-octadecahydropicene-4a-carboxylate;CDDO-Methyl ester;methyl 2-cyano-3,12-. CAS No. 218600-53-4. Molecular formula: C32H43NO4. Mole weight: 505.7g/mol. Appearance: Solid. Purity: 0.9972. IUPACName: methyl (4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicene-4a-carboxylate. Canonical SMILES: CC1 (CCC2 (CCC3 (C (C2C1)C (=O)C=C4C3 (CCC5C4 (C=C (C (=O)C5 (C)C)C#N)C)C)C)C (=O)OC)C. ECNumber: 606-850-4. Catalog: ACM218600534. | |
| Bardoxolone methyl | Bardoxolone methyl. Group: Biochemicals. Alternative Names: CDDO-methyl ester. Grades: Highly Purified. CAS No. 218600-53-4. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C32H43NO4. US Biological Life Sciences. | Worldwide |
| Bardoxolone methyl | Bardoxolone methyl (also known as "RTA 402" and "CDDO-methyl ester") is an orally-available first-in-class synthetic triterpenoid belonging to the antioxidant inflammation modulator (AIM) class. It is the most potent known inducer of the Nrf2 pathway to enter clinical development and works to suppress both oxidative stress and inflammation. Uses: A nrf2 activator that inhibits proliferation and induces differentiation and apoptosis in various cancer cells; antioxidant inflammation modulator (aim); for the treatment of advanced chronic kidney disease (ckd) in type 2 diabetes mellitus patients. Synonyms: CDDO Methyl ester; CDDOMe; RTA 402; RTA-402; RTA402; TP-155; TP155; TP 155; 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid methyl ester; bardoxolone methyl; CDDO-Me; methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate; (4aS,6aR,6bS,8aR,12aS,14bS)-Methyl 11-cyano-2, 2, 6a, 6b, 9, 9, 12a-heptamethyl-10, 14-dioxo-1, 2, 3, 4, 4a, 5, 6, 6a, 6b, 7, 8, 8a, 9, 10, 12a, 14, 14a, 14b-octadecahydropicene-4a-carboxylate. Grades: ≥ 98.0%. CAS No. 218600-53-4. Molecular formula: C32H43NO4. Mole weight: 505.70. | |
| BARETab PH | BARETab PH. Medium particle size, BARETab PH is a high functionality homogeneous co-processed compound composed of binder, glidant, disintegrant, and lubricant. The unique co-processing technology confers superior flowability, compaction, lubricity, disintegration, stability, and content uniformity. The performance of BARETab PH is superior compared to the individual excipients or their simple physical mix. Dosage Form: Tablet. Functionality: Multifunctional, Binder, Glidant, Lubricant, Disintegrant, Natural Origin, Tablet Compressibility. Process: Direct Compression. Particle Size: 120 Microns. |  Sigachi US Inc |
| BARETab TM PH | BARETab TM PH. Medium particle size, BARETabTM PH is a high functionality homogeneous co-processed compound compose of binder, glidant, disintegrant and lubricant. CO-processing makes the product superior in flowability, compaction, lubricity, disintegration, stability and content uniformity. BARETab PH performance is superior compared to the individual excipients or their physical mixing. Dosage Form: Tablet. Functionality: Multifunctional, Binder, Glidant, Lubricant, Disintegrant, Natural Origin, Tablet Compressibility. Process: Direct Compression. Particle Size: 120 Microns. | Sigachi US Inc |
| Barfoed Reagent, Laboratory Grade, 100 mL | Storage Code: Green; general chemical storage. Grades: chem-grade laboratory. Product ID: 846625. -- SOLD FOR EDUCATIONAL USE ONLY -- |  |
| Bar I | One unit of the enzyme is the amount required to hydrolyze 1 μg of T7 DNA in 1 hour at 37°C in a total reaction volume of 50 μl. Applications: After 2-fold overdigestion with enzyme 90% of dna fragments can be ligated. of these 95% can be recut. Group: Restriction Enzymes. Purity: 100U; 500U. ↑(N)7GAAGNNNNNNTAC(N)12↑ ↓(N)12CTTCNNNNNNATG(N)7&darr. Activity: 500-2000 500-2000u.a./ml. Appearance: 10 X SE-buffer 2K. Storage: -20°C. Form: Liquid. Source: Bacillus sphaericus. Pack: 20 mM KH2PO4(pH 7.4); 100 mM KCl; 0,1 mM EDTA; 7 mM 2-mercaptoethanol; 200 μg/ml BSA, 50% glycerol. Cat No: ET-1031RE. | |
| Baricitinib | Baricitinib is a selective and orally bioactive inhibitor of JAK1 and JAK2. It has been approved by FDA for the treatment of rheumatoid arthritis (RA). Uses: The treatment of rheumatoid arthritis (ra). Synonyms: LY3009104; 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile; Olumiant. Grades: >98%. CAS No. 1187594-09-7. Molecular formula: C16H17N7O2S. Mole weight: 371.419. | |
| Baricitinib | Baricitinib. Alternative Names: 1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile. CAS No. 1187594-09-7. Molecular formula: C16H17N7O2S. Mole weight: 371.42. Appearance: White to off-white solid. Purity: 0.98. IUPACName: 2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile. Canonical SMILES: CCS (=O) (=O)N1CC (C1) (CC#N)N2C=C (C=N2)C3=C4C=CNC4=NC=N3. Catalog: ACM1187594097. | |
| Baricitinib | Baricitinib Inhibitor. Uses: Scientific use. Product Category: T2485. CAS No. 1187594-09-7. |  |
| Baricitinib | Baricitinib. Group: Biochemicals. Alternative Names: INCB 028050; LY 3009104; 1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile. Grades: Highly Purified. CAS No. 1187594-09-7. Pack Sizes: 5mg. Molecular Formula: C16H17N7O2S, Molecular Weight: 371.42. US Biological Life Sciences. | Worldwide |
| Baricitinib impurity 10 | Baricitinib impurity 10. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2166596-69-4. Molecular Formula: C12H19N3O2Si. Mole Weight: 265.39. Catalog: APB2166596694. | |
| Baricitinib Impurity 10 | Baricitinib Impurity 10. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole. CAS No. 1029716-44-6. Molecular Formula: C13H23BN2O3. Mole Weight: 266.14. Catalog: APB1029716446. | |
| Baricitinib impurity 11 | Baricitinib impurity 11. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C12H17Cl2N3OSi. Mole Weight: 318.27. Catalog: APB11262. | |
| Baricitinib Impurity 11 | Baricitinib Impurity 11. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (1-(1-ethoxyethyl)-1H-pyrazol-4-yl)boronic acid. CAS No. 2227194-01-4. Molecular Formula: C7H13BN2O3. Mole Weight: 184.00. Catalog: APB2227194014. | |
| Baricitinib impurity 12 | Baricitinib impurity 12. Uses: For analytical and research use. Group: Impurity standards. CAS No. 894807-98-8. Molecular Formula: C15H29BN2O3Si. Mole Weight: 324.3. Catalog: APB894807988. | |
| Baricitinib Impurity 13 | Baricitinib Impurity 13. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4-(1-(1-ethoxyethyl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methanol. CAS No. 2761352-71-8. Molecular Formula: C14H17N5O2. Mole Weight: 287.32. Catalog: APB2761352718. | |
| Baricitinib impurity 14 | Baricitinib impurity 14. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C17H21N7O4S. Mole Weight: 419.46. Catalog: APB11263. | |
| Baricitinib Impurity 14 | Baricitinib Impurity 14. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine. CAS No. 952518-97-7. Molecular Formula: C9H7N5. Mole Weight: 185.19. Catalog: APB952518977. | |
| Baricitinib Impurity 15 | Baricitinib Impurity 15. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methanol. Molecular Formula: C10H9N5O. Mole Weight: 215.21. Catalog: APB03631. | |
| Baricitinib impurity 16 | Baricitinib impurity 16. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C15H15N7O. Mole Weight: 309.33. Catalog: APB11264. | |
| Baricitinib Impurity 16 | Baricitinib Impurity 16. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-(3-(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile. CAS No. 2402776-84-3. Molecular Formula: C23H27N9O4S2. Mole Weight: 557.65. Catalog: APB2402776843. | |
| Baricitinib Impurity 17 | Baricitinib Impurity 17. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetamide. Molecular Formula: C22H33N7O4SSi. Mole Weight: 519.69. Catalog: APB03629. | |
| Baricitinib Impurity 18 | Baricitinib Impurity 18. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile. Molecular Formula: C22H31N7O3SSi. Mole Weight: 501.68. Catalog: APB03630. | |
| Baricitinib impurity 19 | Baricitinib impurity 19. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C7H7N3O2. Mole Weight: 165.15. Catalog: APB11265. | |
| Baricitinib Impurity 19 | Baricitinib Impurity 19. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: methyl 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetate. CAS No. 2402776-80-9. Molecular Formula: C17H20N6O4S. Mole Weight: 404.44. Catalog: APB2402776809. | |
| Baricitinib impurity 20 | Baricitinib impurity 20. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C19H21N7O2. Mole Weight: 379.42. Catalog: APB11266. | |
| Baricitinib Impurity 20 | Baricitinib Impurity 20. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-(3-aminopropyl)azepan-2-one. CAS No. 24566-95-8. Molecular Formula: C9H18N2O. Mole Weight: 170.25. Catalog: APB24566958. | |
| Baricitinib Impurity 23 | Baricitinib Impurity 23. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-(3-(4-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile. Molecular Formula: C22H20N10O2S. Mole Weight: 488.53. Catalog: APB03616. | |
| Baricitinib impurity 25 | Baricitinib impurity 25. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1401222-91-0. Molecular Formula: C5H9NO3S. Mole Weight: 163.19. Catalog: APB1401222910. | |
| Baricitinib Impurity 25 | Baricitinib Impurity 25. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-(1-(ethylsulfonyl)-3-(4-(7-(ethylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile. Molecular Formula: C18H21N7O4S2. Mole Weight: 463.53. Catalog: APB01313. | |
| Baricitinib Impurity 26 | Baricitinib Impurity 26. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(butylsulfonyl)azetidin-3-yl)acetonitrile. Molecular Formula: C18H21N7O2S. Mole Weight: 399.47. Catalog: APB03615. | |
| Baricitinib Impurity 27 | Baricitinib Impurity 27. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-(3-(4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile. CAS No. 2402776-83-2. Molecular Formula: C16H17N7O2S. Mole Weight: 371.12. Catalog: APB2402776832. | |
| Baricitinib Impurity 27 (Hydrochloride) | Baricitinib Impurity 27 (Hydrochloride). Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-(3-(4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile hydrochloride. Molecular Formula: C16H17N7O2S·HCl. Mole Weight: 407.58. Catalog: APB03614. | |
| Baricitinib Impurity 28 | Baricitinib Impurity 28. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 7H,7'H-4,4'-bipyrrolo[2,3-d]pyrimidine. Molecular Formula: C12H8N6. Mole Weight: 236.08. Catalog: APB03612. | |
| Baricitinib Impurity 29 | Baricitinib Impurity 29. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: tert-butyl 3-(4-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)-1H-pyrazol-1-yl)-3-(cyanomethyl)azetidine-1-carboxylate. Molecular Formula: C19H21N7O3. Mole Weight: 395.17. Catalog: APB01312. | |
| Baricitinib Impurity 3 | Baricitinib Impurity 3. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetamide. CAS No. 2271228-51-2. Molecular Formula: C16H19N7O3S. Mole Weight: 389.43. Catalog: APB2271228512. | |
| Baricitinib Impurity 30 | Baricitinib Impurity 30. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 4,4'-oxybis(7H-pyrrolo[2,3-d]pyrimidine). Molecular Formula: C12H8N6O. Mole Weight: 252.08. Catalog: APB03613. | |
| Baricitinib Impurity 32 | Baricitinib Impurity 32. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 7H-4,7'-bipyrrolo[2,3-d]pyrimidine. Molecular Formula: C12H8N6. Mole Weight: 236.08. Catalog: APB01311. | |
| Baricitinib Impurity 33 | Baricitinib Impurity 33. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine. CAS No. 134965-85-8. Molecular Formula: C12H7ClN6. Mole Weight: 270.04. Catalog: APB134965858. | |
| Baricitinib Impurity 34 | Baricitinib Impurity 34. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-ol. Molecular Formula: C12H8N6O. Mole Weight: 252.08. Catalog: APB01283. | |
| Baricitinib Impurity 35 | Baricitinib Impurity 35. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 7'H-[3,4'-bipyrrolo[2,3-d]pyrimidin]-4(7H)-one. Molecular Formula: C12H8N6O. Mole Weight: 252.08. Catalog: APB03611. | |
| Baricitinib impurity 36 (hydrochloride) | Baricitinib impurity 36 (hydrochloride). Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-(3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile hydrochloride. CAS No. 1416785-40-4. Molecular Formula: C14H21BN4O2·HCl. Mole Weight: 324.61. Catalog: APB1416785404. | |
| Baricitinib impurity 37 | Baricitinib impurity 37. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-(1-(ethylsulfonyl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile. CAS No. 1919837-50-5. Molecular Formula: C16H25BN4O4S. Mole Weight: 380.27. Catalog: APB1919837505. | |
